BIOMEDICALSCIENCES RESEARCH CENTER ALEXA...
Desconocido
Mostrando
1
al
20
de
64
resultados
MASSTRUCT: ERA CHAIR HOLDER TO ESTABLISH BIOMOLECULAR AND STRUCTURAL MASS SPECTROMETRY FOR THE ANALYSIS OF COMP...
"MASSTRUCT aims at establishing a world class Biomolecular Mass Spectrometry Research Unit and Facility for Excellence in the Biomedical Sci...
2024-10-16 - 2030-02-28 | Financiado
2024-10-16 - 2030-02-28 | Financiado
INFRAPLUS: Enhancing and Evolving INFRAFRONTIER Disease Modelling Capacity to Enable Breakthrough Research
EREVNITIKO KENTRO VIOIATRIKON EPISTIMON ALEXANDROS FLEMINGK
participó en un
HORIZON EUROPE:
HORIZON-INFRA-2023-DEV-01
In response to the HORIZON-INFRA-2023-DEV-01-03 call, INFRAPLUS aims to expand INFRAFRONTIER's capacity for human disease modelling, refine...
2024-06-20 - 2027-05-31 | Financiado
2024-06-20 - 2027-05-31 | Financiado
ELIXIR-STEERS: ELIXIR STEERS
EREVNITIKO KENTRO VIOIATRIKON EPISTIMON ALEXANDROS FLEMINGK
participó en un
HORIZON EUROPE:
HORIZON-INFRA-2023-DEV-01
ELIXIR unites Europe’s leading life science organisations in managing and safeguarding the increasing volume of data being generated by publ...
2023-11-03 - 2027-01-31 | Financiado
2023-11-03 - 2027-01-31 | Financiado
ProMisMe: Bioengineered microbes as a platform for discovering chemical rescuers of disease-related misfolding...
EREVNITIKO KENTRO VIOIATRIKON EPISTIMON ALEXANDROS FLEMINGK
tramitó un
HORIZON EUROPE:
HORIZON-WIDERA-2022-TALENTS-04
Protein misfolding diseases (PMDs) are a large group of human disorders caused by the misfolding of specific proteins. They include conditio...
2023-10-19 - 2026-06-30 | Financiado
2023-10-19 - 2026-06-30 | Financiado
RIA4FOOD: Multi-Actor Research and Innovation Approaches for Functional Food
EREVNITIKO KENTRO VIOIATRIKON EPISTIMON ALEXANDROS FLEMINGK
participó en un
HORIZON EUROPE:
HORIZON-MSCA-2022-SE-01
Keeping up with the dramatic increase in world-food needs is a challenging task. Food supply is further affected by the latest consumers’ di...
2023-09-20 - 2027-10-31 | Financiado
2023-09-20 - 2027-10-31 | Financiado
artFibro: Artifying fibroblasts: Perturbation modelling in the lung tumor phase space to rewire fibroblasts fo...
EREVNITIKO KENTRO VIOIATRIKON EPISTIMON ALEXANDROS FLEMINGK
tramitó un
HORIZON EUROPE:
ERC-2022-COG
Lung cancer is the leading cause of cancer death. Immunotherapy improved survival rates, but efficacy is limited to selected patients. We re...
2023-03-27 - 2028-03-31 | Financiado
2023-03-27 - 2028-03-31 | Financiado
Boost4Bio: Boosting Bio-Innovation and Bio-Entrepreneurship by Establishing Excellence in Biomolecular Engineer...
EREVNITIKO KENTRO VIOIATRIKON EPISTIMON ALEXANDROS FLEMINGK
tramitó un
HORIZON EUROPE:
HORIZON-WIDERA-2022-TALENTS-01
The Biomedical Sciences Research Center Alexander Fleming (FLEMING) is the top-ranked research center in the Life Sciences in Greece. FLEMIN...
2022-11-09 - 2027-12-31 | Financiado
2022-11-09 - 2027-12-31 | Financiado
TIER2: TIER2: ENHANCING TRUST, INTEGRITY AND EFFICIENCY IN RESEARCH THROUGH NEXT-LEVEL REPRODUCIBILITY IMPA...
EREVNITIKO KENTRO VIOIATRIKON EPISTIMON ALEXANDROS FLEMINGK
participó en un
HORIZON EUROPE:
HORIZON-WIDERA-2022-ERA-01
Lack of reproducibility of research results has become a major theme in recent years. As we emerge from the COVID-19 pandemic, economic pres...
2022-11-07 - 2025-12-31 | Financiado
2022-11-07 - 2025-12-31 | Financiado
REACT: Respiratory Host Pathogen Interaction
Lower respiratory tract infections resulting from seasonal epidemics and pandemics are among the leading causes of death globally. There is...
2022-05-25 - 2026-07-31 | Financiado
2022-05-25 - 2026-07-31 | Financiado
BecomingCausal: Contextual specification of fibroblast-driven causalities in chronic intestinal inflammation and fib...
EREVNITIKO KENTRO VIOIATRIKON EPISTIMON ALEXANDROS FLEMINGK
tramitó un
HORIZON EUROPE:
ERC-2021-ADG
Inflammatory bowel disease (IBD) is a severe, chronic pathology presenting with progressive intestinal inflammation and fibrosis, whose exac...
2022-05-13 - 2027-05-31 | Financiado
2022-05-13 - 2027-05-31 | Financiado
ELIXIR-CONVERGE: Connect and align ELIXIR Nodes to deliver sustainable FAIR life science data management services
EREVNITIKO KENTRO VIOIATRIKON EPISTIMON ALEXANDROS FLEMINGK
participó en un
H2020:
H2020-INFRADEV-2018-2020
The diversity, complexity and volume, as well as privacy and regulatory considerations, necessitate a collaborative and federated approach t...
2020-02-06 - 2023-07-31 | Financiado
2020-02-06 - 2023-07-31 | Financiado
ERMADA: Illuminating Earth s microbial diversity and origins from metagenomes with deep learning
EREVNITIKO KENTRO VIOIATRIKON EPISTIMON ALEXANDROS FLEMINGK
tramitó un
H2020:
H2020-MSCA-IF-2018
The estimated number of microbes on our planet outnumbers the stars of the Milky Way galaxy and their biomass exceeds that of all plants and...
2019-04-01 - 2025-01-03 | Financiado
2019-04-01 - 2025-01-03 | Financiado
ProMiDis: A unified drug discovery platform for protein misfolding diseases
EREVNITIKO KENTRO VIOIATRIKON EPISTIMON ALEXANDROS FLEMINGK
tramitó un
H2020:
ERC-2018-COG
It is now widely recognized that a variety of major diseases, such as Alzheimer’s disease, Huntington’s disease, systemic amyloidosis, cysti...
2019-02-01 - 2026-06-30 | Financiado
2019-02-01 - 2026-06-30 | Financiado
EOSC-Life: Providing an open collaborative space for digital biology in Europe
EREVNITIKO KENTRO VIOIATRIKON EPISTIMON ALEXANDROS FLEMINGK
participó en un
H2020:
H2020-INFRAEOSC-2018-2020
EOSC-Life brings together the 13 Biological and Medical ESFRI research infrastructures (BMS RIs) to create an open collaborative space for...
2018-11-20 - 2023-08-31 | Financiado
2018-11-20 - 2023-08-31 | Financiado
* No se disponen de datos de la empresa actual.